News in Brief

The document reported on various studies in the field of endocrinology and metabolism. A study involving 59 post-menopausal women at Oregon Health & Science University found that 58% of breast cancer survivors had fallen in the past year, suggesting an increased risk of falls due to chemotherapy and endocrine therapy. Another study by Archimedes Inc. demonstrated through a mathematical model that tamoxifen chemoprophylaxis could prevent 29 breast cancer cases and nine deaths per 1000 women treated who are under 55 with a 5-year risk of 1.66% or greater. The University of Melbourne developed new guidelines for androgen-deprivation therapy in non-metastatic prostate cancer, recommending caution due to significant side effects. A study from Paris Descartes University and European Georges Pompidou Hospital found that men who start losing their hair at age 20 may be at a higher risk of prostate cancer. Michael Yassa from Paris Descartes University called for more research to understand the link between androgens, early balding, and prostate cancer, suggesting that early diagnosis of prostate cancer could potentially be improved by screening men with early-onset androgenic alopecia.